[1]
Fazio G,Giovino M,Gullotti A,Bacarella D,Novo G,Novo S, Atherosclerosis, inflammation and Chlamydia pneumoniae. World journal of cardiology. 2009 Dec 31;
[PubMed PMID: 21160574]
[2]
Cui K,Lyu S,Song X,Liu H,Yuan F,Xu F,Zhang M,Wang W,Zhang M,Zhang D,Tian J, Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease. The American journal of cardiology. 2019 Aug 1;
[PubMed PMID: 31174834]
[3]
Pimor A,Auffret V,Didier R,Delaunay R,Filippi E,Hacot JP,Saouli D,Rouault G,Druelles P,Bot E,Coudert I,Boulanger B,Le Guellec M,Boulmier D,Leurent G,Bedossa M,Gilard M,Le Breton H, Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: Insights from the ORBI registry. Archives of cardiovascular diseases. 2018 Nov;
[PubMed PMID: 29229216]
[4]
Widimsky P,Holmes DR Jr, How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? European heart journal. 2011 Feb;
[PubMed PMID: 21118854]
[5]
Mohr FW,Morice MC,Kappetein AP,Feldman TE,Ståhle E,Colombo A,Mack MJ,Holmes DR Jr,Morel MA,Van Dyck N,Houle VM,Dawkins KD,Serruys PW, Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet (London, England). 2013 Feb 23;
[PubMed PMID: 23439102]
Level 1 (high-level) evidence
[6]
Serruys PW,Morice MC,Kappetein AP,Colombo A,Holmes DR,Mack MJ,Ståhle E,Feldman TE,van den Brand M,Bass EJ,Van Dyck N,Leadley K,Dawkins KD,Mohr FW, Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. The New England journal of medicine. 2009 Mar 5;
[PubMed PMID: 19228612]
[7]
Al Badarin FJ,Malhotra S, Diagnosis and Prognosis of Coronary Artery Disease with SPECT and PET. Current cardiology reports. 2019 May 18;
[PubMed PMID: 31104158]
[8]
Rossini R,Musumeci G,Navarese EP,Tarantini G, Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions. American journal of cardiovascular disease. 2013;
[PubMed PMID: 23459399]
[9]
Kolkailah AA,Alreshq RS,Muhammed AM,Zahran ME,Anas El-Wegoud M,Nabhan AF, Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease. The Cochrane database of systematic reviews. 2018 Apr 18;
[PubMed PMID: 29665617]
Level 1 (high-level) evidence
[10]
Silvain J,Collet JP,Nagaswami C,Beygui F,Edmondson KE,Bellemain-Appaix A,Cayla G,Pena A,Brugier D,Barthelemy O,Montalescot G,Weisel JW, Composition of coronary thrombus in acute myocardial infarction. Journal of the American College of Cardiology. 2011 Mar 22;
[PubMed PMID: 21414532]
[11]
Fihn SD,Blankenship JC,Alexander KP,Bittl JA,Byrne JG,Fletcher BJ,Fonarow GC,Lange RA,Levine GN,Maddox TM,Naidu SS,Ohman EM,Smith PK, 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2014 Nov 4;
[PubMed PMID: 25077860]
Level 1 (high-level) evidence
[12]
Psaty BM,Furberg CD,Kuller LH,Bild DE,Rautaharju PM,Polak JF,Bovill E,Gottdiener JS, Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Archives of internal medicine. 1999 Jun 28;
[PubMed PMID: 10386510]
[13]
Berry C,Collison D,Mangion K, Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When? JACC. Cardiovascular interventions. 2019 Apr 22;
[PubMed PMID: 31000011]
[14]
Head SJ,Milojevic M,Daemen J,Ahn JM,Boersma E,Christiansen EH,Domanski MJ,Farkouh ME,Flather M,Fuster V,Hlatky MA,Holm NR,Hueb WA,Kamalesh M,Kim YH,Mäkikallio T,Mohr FW,Papageorgiou G,Park SJ,Rodriguez AE,Sabik JF 3rd,Stables RH,Stone GW,Serruys PW,Kappetein AP, Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet (London, England). 2018 Mar 10;
[PubMed PMID: 29478841]
[15]
Hlatky MA,Boothroyd DB,Baker L,Kazi DS,Solomon MD,Chang TI,Shilane D,Go AS, Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Annals of internal medicine. 2013 May 21;
[PubMed PMID: 23609014]
Level 2 (mid-level) evidence
[16]
Thuijs DJFM,Kappetein AP,Serruys PW,Mohr FW,Morice MC,Mack MJ,Holmes DR Jr,Curzen N,Davierwala P,Noack T,Milojevic M,Dawkins KD,da Costa BR,Jüni P,Head SJ, Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet (London, England). 2019 Oct 12;
[PubMed PMID: 31488373]
Level 1 (high-level) evidence
[17]
Bangalore S,Guo Y,Samadashvili Z,Blecker S,Xu J,Hannan EL, Everolimus-eluting stents or bypass surgery for multivessel coronary disease. The New England journal of medicine. 2015 Mar 26;
[PubMed PMID: 25775087]